Estrogen Receptor Agonist Market - Top Companies and Manufacturers

Companies Dominating the Estrogen Receptor Agonist Landscape

AstraZeneca
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Eli Lilly and Company
ESTRIGENIX
Karo Healthcare AB
Merck KGaA
Vivesto AB
Oncternal Therapeutics
Pfizer Inc.
Tocris Bioscience
Tokyo Chemical Industry Co., Ltd

Browse Key Market Insights with Data Illustration:

Estrogen Receptor Agonist Market Forecast Report 2025-2037

In the News

Positive high-level findings from the FLAURA2 Phase III trial showed that Tagrisso (osimertinib) from AstraZeneca improved progression-free survival (PFS) among individuals with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) more significantly when combined with chemotherapy than when used alone.
On Thursday, October 27, and Friday, October 28, at the Grand Hyatt at San Francisco Airport, located at 55 South McDonnell Road in San Francisco, Estrigenix Therapeutics, Inc. presented new research on hormone replacement treatment.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of estrogen receptor agonist is evaluated at USD 5.21 billion.

The estrogen receptor agonist market size was valued at USD 4.63 billion in 2024 and is set to exceed USD 12 billion by 2037, registering over 7.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of osteoporosis, the rise in women suffering from PCOS, and the surge in the application of estrogen in asthma.

Asia Pacific industry is predicted to dominate majority revenue share by 2037, backed by growing geriatric population in this region.

The major players in the market are AstraZeneca, Eli Lilly and Company, ESTRIGENIX, Karo Healthcare AB, Merck KGaA, Vivesto AB, Oncternal Therapeutics, Pfizer Inc., Tocris Bioscience, Tokyo Chemical Industry Co., Ltd

Estrogen Receptor Agonist Market - Top Companies and Manufacturers

Companies Dominating the Estrogen Receptor Agonist Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the estrogen receptor agonist market worth?

Why is the demand for estrogen receptor agonist growing?

Which region dominated the majority of estrogen receptor agonist industry share?

Who are the top estrogen receptor agonist companies?